Abstract
Psychedelics have emerged as promising candidate treatments for various psychiatric conditions, and given their clinical potential, there is a need to identify biomarkers that underlie their effects. Here, we investigate the neural mechanisms of lysergic acid diethylamide (LSD) using regression dynamic causal modelling (rDCM), a novel technique that assesses whole-brain effective connectivity (EC) during resting-state functional magnetic resonance imaging (fMRI). We modelled data from two randomised, placebo-controlled, double-blind, cross-over trials, in which 45 participants were administered 100 μg LSD and placebo in two resting-state fMRI sessions. We compared EC against whole-brain functional connectivity (FC) using classical statistics and machine learning methods. Multivariate analyses of EC parameters revealed predominantly stronger interregional connectivity and reduced self-inhibition under LSD compared to placebo, with the notable exception of weakened interregional connectivity and increased self-inhibition in occipital brain regions as well as subcortical regions. Together, these findings suggests that LSD perturbs the Excitation/Inhibition balance of the brain. Notably, whole-brain EC did not only provide additional mechanistic insight into the effects of LSD on the Excitation/Inhibition balance of the brain, but EC also correlated with global subjective effects of LSD and discriminated experimental conditions in a machine learning-based analysis with high accuracy (91.11%), highlighting the potential of using whole-brain EC to decode or predict subjective effects of LSD in the future.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Neuropsychopharmacology |
| Jahrgang | 48 |
| Ausgabenummer | 8 |
| Seiten (von - bis) | 1175-1183 |
| Seitenumfang | 9 |
| ISSN | 0893-133X |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 07.2023 |
Fördermittel
We are grateful for support from the Swiss National Science Foundation (trial A: SNF project grant, 320030_1449493 to MEL, trial B: SNF project grant, 320030_170249 to SB and MEL, Doc.Mobility, P1BSP3_200054 to DJH, Ambizione, PZ00P3_167952 to AOD) and the Krembil Foundation (to AOD).
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
-
SDG 10 – Weniger Ungleichheiten
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)
DFG-Fachsystematik
- 2.23-04 Kognitive, systemische und Verhaltensneurobiologie
- 2.22-09 Pharmakologie
- 2.23-09 Biologische Psychiatrie
Fingerprint
Untersuchen Sie die Forschungsthemen von „The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver